Georgia Medicare Obesity Counseling IBT 2026 Guide

By Brevy Care Team · Last verified May 14, 2026

The Medicare Intensive Behavioral Therapy (IBT) for Obesity benefit gives every eligible Georgia Medicare beneficiary with a body mass index of 30 kilograms per square meter or higher the right to a structured, multi-session, primary-care-based behavioral therapy intervention designed to support meaningful weight loss across a 12-month period. The benefit was established through CMS coverage decision under Section 1861(ddd) of the Social Security Act preventive services authority and codified as National Coverage Determination 210.12 effective November 29, 2011, making it one of the earliest behavioral counseling preventive services in the modern Medicare preventive services framework. The benefit's design reflects a particular theory of obesity care that differs sharply from older Medicare obesity coverage frameworks: rather than treating obesity primarily as a precursor condition that triggers downstream eligibility for bariatric surgery, the IBT benefit treats obesity as a chronic condition for which a sustained, primary-care-delivered behavioral intervention is the appropriate first-line treatment, with bariatric surgery and pharmacotherapy as adjuncts available to beneficiaries whose obesity warrants more intensive intervention or whose response to behavioral therapy alone is insufficient.

The IBT for Obesity benefit is structured around three core design features. First, the eligibility threshold is BMI ≥30 kg/m², which corresponds to the World Health Organization and CDC clinical definition of obesity and aligns with the United States Preventive Services Task Force recommendation that supports the benefit. Second, the session schedule is intensive in the first six months and tapered across the second six months: weekly sessions for the first month, every-other-week sessions for months two through six, and monthly sessions for months six through twelve. Third, continued eligibility for the monthly sessions in months six through twelve is conditional on the beneficiary having achieved at least 6.6 pounds (3 kilograms) of weight loss by the six-month assessment. Beneficiaries who do not meet the six-month threshold are not eligible for the months 6-12 portion of the benefit during that 12-month cycle but become eligible for a fresh 12-month course if their BMI remains ≥30 kg/m² and they are referred for another IBT course.

The benefit is billed under two HCPCS codes: G0447 for 15-minute face-to-face individual IBT sessions and G0473 for group IBT sessions. The screening and counseling must be furnished in a primary care setting by a qualified primary care provider. Under the Affordable Care Act Section 4104 cost-sharing waiver, beneficiaries owe nothing out of pocket: no Part B deductible, no 20% coinsurance.

For Georgia Medicare beneficiaries, the IBT benefit operates within a state landscape that includes substantial obesity prevalence across multiple demographic groups, a robust academic and community-based bariatric surgery network anchored by programs at Emory, Wellstar, Piedmont, Northside, Augusta University, and Atrium Health Navicent, an evolving anti-obesity pharmacotherapy landscape that has been substantially reshaped since 2021 by the FDA approval of GLP-1 receptor agonists for chronic weight management (semaglutide marketed as Wegovy approved June 2021, tirzepatide marketed as Zepbound approved November 2023), and the 2024 CMS reinterpretation extending Medicare Part D coverage of GLP-1 receptor agonists for cardiovascular disease indications under the SELECT trial results.

This guide explains how the IBT for Obesity benefit works statutorily and clinically, what eligibility looks like for a Georgia Medicare beneficiary, how the session schedule unfolds across the 12-month period, how the six-month weight loss threshold operates, what cost-sharing applies (none, when the workflow is performed properly), how the benefit coordinates with the Annual Wellness Visit and the Initial Preventive Physical Examination, how it coordinates with Medicare bariatric surgery coverage under NCD 100.1 (and the substantial 2024 modernization of that NCD), how it coordinates with anti-obesity medication coverage including the 2024 GLP-1 receptor agonist cardiovascular indication expansion, and what the Georgia obesity treatment landscape looks like for both primary care delivery of the IBT benefit and for the specialty bariatric and obesity medicine infrastructure that backs it up.

Key Takeaways for Georgia Medicare Beneficiaries

1. Section 1861(ddd) of the Social Security Act authorizes Medicare to cover additional preventive services. The IBT for Obesity benefit was added under this authority through CMS national coverage determination NCD 210.12 effective November 29, 2011.

2. NCD 210.12 — Intensive Behavioral Therapy for Obesity authorizes a multi-session behavioral therapy intervention for Medicare beneficiaries with BMI ≥30 kg/m² when furnished in a primary care setting by a qualified primary care provider. The benefit is structured around a weekly-biweekly-monthly session schedule across a 12-month period.

3. HCPCS G0447 (Face-to-face behavioral counseling for obesity, 15 minutes) is the individual session code. HCPCS G0473 (Face-to-face behavioral counseling for obesity, group, 30 minutes, 2-10 patients) is the group session code. Both codes require primary care setting and qualified primary care provider documentation.

4. The session schedule allows up to 22 sessions in the first 6 months: weekly visits for one month (approximately 4 sessions), every-other-week visits through month 6 (approximately 10 additional sessions, for a total of approximately 14 in months 1-6), and monthly visits for months 7-12 (approximately 6 additional sessions) conditional on the beneficiary meeting the six-month weight loss threshold.

5. The 6.6 pound (3 kg) six-month weight loss threshold determines continued eligibility for monthly sessions in months 7-12. Beneficiaries who do not achieve at least 6.6 pounds of weight loss by the six-month assessment are not eligible for the months 7-12 monthly sessions during that 12-month cycle but may be re-evaluated and start a fresh IBT course if clinically appropriate.

6. Primary care setting requirement means the IBT must be furnished in a primary care setting such as family medicine, internal medicine, geriatric medicine, federally qualified health centers, and rural health clinics. Emergency department, inpatient hospital, specialty (e.g., endocrinology, bariatric surgery), and other non-primary-care settings do not qualify for the benefit.

7. Qualified primary care provider requirement means the IBT must be furnished by a primary care physician (MD or DO), nurse practitioner, physician assistant, or clinical nurse specialist practicing in a primary care setting. Registered dietitians, certified diabetes educators, and licensed nutrition professionals are not the qualifying providers under NCD 210.12 (though they may furnish related but separately billable services under different Medicare codes such as Medicare Diabetes Prevention Program services and Medical Nutrition Therapy).

8. ACA Section 4104 waives the Part B deductible and the standard 20% coinsurance for Medicare preventive services that align with USPSTF Grade A or Grade B recommendations and that CMS has specifically designated. The IBT for Obesity benefit aligns with the USPSTF Grade B recommendation for behavioral weight loss interventions (2018 update; Grade B for adults with BMI ≥30), so cost-sharing is zero when the workflow is performed properly.

9. Coordination with the Annual Wellness Visit (Section 1861(hhh)) and the Initial Preventive Physical Examination (Section 1861(ww)) is natural. Both visits include a BMI calculation as part of the standard health risk assessment, and a BMI ≥30 finding during the AWV or IPPE may trigger the IBT pathway.

10. For Georgia beneficiaries, the IBT benefit operates within a state landscape that includes substantial obesity prevalence, a strong bariatric surgery network anchored by Emory, Wellstar, Piedmont, Northside, Augusta University, and Atrium Health Navicent, an evolving GLP-1 receptor agonist pharmacotherapy landscape, and the 2024 modernization of both NCD 100.1 (bariatric surgery facility certification removal) and the CMS reinterpretation of GLP-1 receptor agonist Part D coverage for cardiovascular indications under the SELECT trial.

The Federal Framework Underlying the Medicare IBT for Obesity Benefit

Section 1861(ddd) of the Social Security Act — Additional Preventive Services Authority

The statutory foundation for the Medicare IBT for Obesity benefit is Section 1861(ddd) of the Social Security Act, codified at 42 U.S.C. 1395x(ddd), added by Section 101(a) of the Medicare Improvements for Patients and Providers Act of 2008 (MIPPA, Public Law 110-275). Section 1861(ddd) authorizes the Secretary of Health and Human Services to designate additional preventive services for Medicare coverage when the Secretary determines, through the national coverage determination process, that those services are reasonable and necessary for the prevention or early detection of an illness or disability, are recommended with a grade of A or B by the United States Preventive Services Task Force, and are appropriate for Medicare beneficiaries.

CMS used this Section 1861(ddd) authority to add the IBT for Obesity benefit through national coverage determination NCD 210.12, finalized effective November 29, 2011. The November 2011 effective date placed IBT for Obesity among the earliest preventive services added under the Section 1861(ddd) authority, alongside the depression screening NCD 210.9 (effective October 14, 2011) and the alcohol misuse screening NCD 210.8 (effective October 14, 2011).

NCD 210.12 — Intensive Behavioral Therapy for Obesity

NCD 210.12 established the IBT for Obesity benefit under three core coverage determinations:

• Eligibility: Medicare beneficiaries with a body mass index of 30 kg/m² or higher are eligible for IBT for Obesity when the therapy is furnished in a primary care setting by a qualified primary care provider.

• Session Schedule: The covered session schedule is structured across a 12-month period as follows:

  • One face-to-face visit every week for the first month.
  • One face-to-face visit every other week for months 2 through 6.
  • One face-to-face visit every month for months 7 through 12, only if the beneficiary has lost at least 3 kilograms (approximately 6.6 pounds) during the first 6 months of intensive therapy.

• Six-month assessment: At the six-month visit, the qualified primary care provider must document whether the beneficiary has achieved the 3 kg (≥6.6 pound) weight loss threshold. Beneficiaries who meet the threshold are eligible for the months 7-12 monthly sessions during the same 12-month cycle. Beneficiaries who do not meet the threshold are not eligible for the months 7-12 monthly sessions during that 12-month cycle and may be evaluated for a fresh IBT course at the next clinical opportunity if BMI remains ≥30 kg/m².

NCD 210.12 grounds the coverage in the USPSTF recommendation framework. The USPSTF has issued recommendations for behavioral weight loss interventions in adults with BMI ≥30 kg/m² since 2003, most recently with a Grade B recommendation in 2018, supporting the ACA Section 4104 cost-sharing waiver applicability.

42 CFR 410.64 — Additional Preventive Services Implementing Regulations

The Section 1861(ddd) statutory authority is implemented through 42 CFR 410.64. For the IBT for Obesity benefit specifically, 42 CFR 410.64 incorporates the NCD 210.12 framework, defining the eligibility threshold, session schedule, six-month threshold, primary care setting requirement, qualified provider requirement, and cost-sharing treatment.

Section 1861(ww) and Section 1861(hhh) Coordination

The IBT for Obesity benefit coordinates naturally with the Initial Preventive Physical Examination (under Section 1861(ww)) and the Annual Wellness Visit (under Section 1861(hhh)). Both visits include BMI calculation as part of the standard health risk assessment. A BMI ≥30 finding during an IPPE or AWV may trigger the IBT pathway, with the IPPE or AWV documenting the BMI threshold and the subsequent or same-day initial IBT session billed under G0447.

ACA Section 4104 Cost-Sharing Waiver

The Affordable Care Act (Public Law 111-148) Section 4104 waives the Part B deductible and the standard 20% coinsurance for Medicare preventive services aligned with USPSTF Grade A or Grade B recommendations and specifically designated by CMS. The IBT for Obesity benefit aligns with the USPSTF Grade B recommendation for behavioral weight loss interventions and is specifically designated under NCD 210.12. Therefore, beneficiaries owe nothing out of pocket for properly billed IBT sessions.

NCD 100.1 — Bariatric Surgery Coverage and the 2024 Reconsideration

The IBT for Obesity benefit coordinates with Medicare bariatric surgery coverage under National Coverage Determination 100.1, which has substantially evolved since its original 2006 finalization. NCD 100.1 covers bariatric surgical procedures for Medicare beneficiaries with BMI ≥35 kg/m² who have at least one obesity-related comorbidity (such as diabetes, hypertension, sleep apnea) and have failed previous medical management of obesity. Covered procedures include:

• Roux-en-Y gastric bypass.
• Laparoscopic adjustable gastric banding.
• Biliopancreatic diversion with duodenal switch.
• Sleeve gastrectomy.

The 2024 NCD 100.1 reconsideration was a substantial modernization of the bariatric surgery coverage framework. The reconsideration:

• Removed the requirement that bariatric surgery be performed at a facility certified by the American College of Surgeons Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) or American Society for Metabolic and Bariatric Surgery (ASMBS), a facility certification requirement that had been part of NCD 100.1 since 2006.
• Broadened access to bariatric surgery for Medicare beneficiaries by allowing the procedures at any Medicare-certified hospital meeting standard quality requirements.

The facility certification removal was viewed as a meaningful expansion of access, particularly in rural and underserved areas where MBSAQIP/ASMBS certified facilities were less available.

Anti-Obesity Medication Coverage Framework

Medicare anti-obesity medication coverage is governed by a complex framework that has substantially evolved since 2021. The relevant features:

• Statutory exclusion: Under Medicare Part D's statutory framework, drugs prescribed for weight loss are generally excluded from Part D coverage. The exclusion dates back to the 2003 Medicare Modernization Act (MMA, Public Law 108-173) which established Part D and listed weight loss drugs among the categories of excluded drugs (alongside drugs for cosmetic purposes, fertility, hair growth, and other defined categories).

• GLP-1 receptor agonist clinical evolution: Semaglutide (marketed as Ozempic for type 2 diabetes, approved December 2017; marketed as Wegovy for chronic weight management, approved June 2021), tirzepatide (marketed as Mounjaro for type 2 diabetes, approved May 2022; marketed as Zepbound for chronic weight management, approved November 2023), and liraglutide (marketed as Victoza for type 2 diabetes, approved 2010; marketed as Saxenda for chronic weight management, approved 2014) are GLP-1 receptor agonists (tirzepatide is a dual GLP-1/GIP receptor agonist) that produce substantial weight loss in addition to their original glycemic indications.

• 2024 CMS reinterpretation under SELECT trial results: The SELECT trial (Semaglutide and Cardiovascular Outcomes in Patients with Overweight or Obesity), published in November 2023, demonstrated that semaglutide 2.4 mg weekly (the Wegovy weight management dose) reduced major adverse cardiovascular events in patients with established cardiovascular disease and BMI ≥27 kg/m² (without diabetes). Based on the SELECT trial results and the March 2024 FDA approval of an additional cardiovascular risk reduction indication for Wegovy, CMS issued guidance in March 2024 (Memo to Part D Sponsors regarding Wegovy and Other Anti-Obesity Medications) clarifying that Part D plans may cover semaglutide (Wegovy) for the cardiovascular risk reduction indication for beneficiaries with established cardiovascular disease and BMI ≥27 kg/m². The reinterpretation did not extend Part D coverage to GLP-1 receptor agonists for primary obesity treatment (weight loss without an established cardiovascular indication), which remains subject to the original Part D weight-loss exclusion.

• Statutory expansion proposals: Several legislative proposals have been introduced to amend the Part D weight loss drug exclusion. As of 2026-05-14, no such amendment has been enacted, and the Part D weight loss drug exclusion remains in effect for primary obesity treatment.

For Medicare beneficiaries engaged in IBT for Obesity, the practical implications of the anti-obesity medication framework are:

• IBT itself does not depend on pharmacotherapy and can be delivered independently.
• Beneficiaries with diabetes who use GLP-1 receptor agonists (Ozempic, Mounjaro) for their primary diabetes indication will typically achieve weight loss as a clinical effect; this weight loss may interact with the IBT six-month threshold determination favorably.
• Beneficiaries with established cardiovascular disease who use Wegovy under the 2024 CMS reinterpretation will similarly achieve weight loss that may interact with IBT threshold determinations.
• Beneficiaries without established cardiovascular disease who would benefit from anti-obesity pharmacotherapy face an out-of-pocket affordability barrier given the Part D weight loss exclusion, with cash prices for Wegovy and Zepbound exceeding $1,000 per month in many markets.

What Eligibility Looks Like for a Georgia Medicare Beneficiary

BMI ≥30 kg/m² Threshold

The primary eligibility criterion is body mass index of 30 kilograms per square meter or higher. BMI is calculated as weight in kilograms divided by height in meters squared. For reference points:

• A 5-foot-6 (1.68 meter) individual weighing 186 pounds (84.4 kg) has a BMI of approximately 30.0 kg/m².
• A 5-foot-10 (1.78 meter) individual weighing 209 pounds (94.8 kg) has a BMI of approximately 30.0 kg/m².
• A 6-foot (1.83 meter) individual weighing 221 pounds (100.2 kg) has a BMI of approximately 30.0 kg/m².

BMI is documented at the IPPE, the AWV, and at most primary care visits. The BMI calculation must be current at the time of IBT initiation.

Primary Care Setting Requirement

The IBT must be furnished in a primary care setting:

• Family medicine.
• Internal medicine.
• Geriatric medicine.
• Federally qualified health centers (FQHCs).
• Rural health clinics (RHCs).

Settings that do not qualify:

• Emergency department.
• Inpatient hospital.
• Specialty practices (e.g., endocrinology, bariatric surgery, sleep medicine) outside the primary care relationship.
• Skilled nursing facilities.
• Hospice.

Qualified Primary Care Provider Requirement

The IBT must be furnished by:

• Physicians (MDs and DOs) practicing in a primary care specialty.
• Nurse practitioners practicing in a primary care setting.
• Physician assistants practicing in a primary care setting.
• Clinical nurse specialists practicing in a primary care setting.

Important note: Registered dietitians, certified diabetes educators, licensed nutrition professionals, and other allied health professionals are not the qualifying providers under NCD 210.12. These providers furnish related but separately billable services under different Medicare codes such as Medicare Diabetes Prevention Program (MDPP) services and Medical Nutrition Therapy (MNT) services. Beneficiaries with diabetes or chronic kidney disease may have MNT coverage as a separate Medicare benefit under Section 1861(s)(2)(V) SSA.

Universal Coverage Across Medicare Programs

The IBT benefit applies equally to:

• Medicare beneficiaries enrolled in Original Medicare (Part B fee-for-service).
• Medicare beneficiaries enrolled in Medicare Advantage (Part C), with the IBT covered as a Part B preventive service that Medicare Advantage plans must cover at no greater cost-sharing than Original Medicare.
• Dual-eligible beneficiaries (Medicare + Georgia Medicaid), with Medicare as the primary payer.

The Session Schedule

The covered session schedule under NCD 210.12 is structured across a 12-month period as follows:

Month 1: Weekly Sessions

Four sessions in the first month, approximately one per week. Initial sessions typically focus on:

• Baseline assessment: weight, BMI, waist circumference, blood pressure, comorbidity review.
• Dietary assessment: typical intake patterns, eating triggers, food environment.
• Physical activity assessment: typical activity patterns, barriers, opportunities.
• Goal-setting: collaborative agreement on initial weight loss target (typically 1-2 pounds per week) and behavioral changes.
• Behavioral self-monitoring: food diary, activity tracking, weight tracking.

Months 2-6: Every-Other-Week Sessions

Approximately 10 additional sessions across months 2-6, with one session every two weeks. Session content typically focuses on:

• Review of self-monitoring data.
• Reinforcement of behavioral changes.
• Problem-solving for barriers.
• Adjustment of goals and strategies based on observed progress.
• Introduction of additional behavioral techniques (stimulus control, cognitive restructuring, social support, relapse prevention).
• Coordination with related care (e.g., physical therapy for joint pain limiting activity, sleep medicine for sleep apnea, psychiatry for mood disorders).

Six-Month Assessment

At the six-month visit, the qualified primary care provider must document:

• Current weight and BMI.
• Total weight loss from baseline.
• Whether the beneficiary has achieved the 3 kg (≥6.6 pound) weight loss threshold.
• Plan for months 7-12 based on the threshold determination.

If the threshold is met, the beneficiary is eligible for the months 7-12 monthly sessions during the same 12-month cycle. If the threshold is not met, the beneficiary is not eligible for the months 7-12 monthly sessions during that 12-month cycle.

Months 7-12: Monthly Sessions (Threshold-Conditional)

If the six-month threshold is met, six additional monthly sessions across months 7-12. Session content typically focuses on:

• Maintenance of weight loss.
• Continued behavioral reinforcement.
• Long-term lifestyle integration.
• Identification of and response to weight regain.
• Preparation for sustained self-management after the 12-month IBT cycle concludes.

After Month 12

After the 12-month IBT cycle concludes, beneficiaries do not automatically continue in the IBT benefit. If their BMI remains ≥30 kg/m², they may be evaluated for a fresh IBT course at the next clinical opportunity. NCD 210.12 does not specify a mandatory interval between IBT courses, but practical clinical patterns typically involve a substantial interval (e.g., 12 months or more between courses) reflecting the chronic nature of obesity management.

Cost-Sharing Under ACA Section 4104

The Affordable Care Act Section 4104 cost-sharing waiver applies to HCPCS G0447 and G0473. When the workflow is performed properly — primary care setting, qualified primary care provider, BMI threshold met, six-month threshold determination documented — the beneficiary owes nothing out of pocket. Specifically:

• The Part B deductible does not apply.
• The standard 20% Part B coinsurance does not apply.
• Medicare pays the entire allowed amount.

Medicare Advantage plans must cover IBT at no greater cost-sharing than Original Medicare, meaning Medicare Advantage enrollees also pay nothing out of pocket for properly billed IBT.

It is important to note that the cost-sharing waiver applies specifically to the HCPCS G0447 and G0473 codes. Downstream services that may follow from IBT — bariatric surgery, sleep medicine evaluation, physical therapy, anti-obesity medication, mental health services for binge eating disorder, endocrinology consultation — are not preventive services and are subject to standard Part B (or Part A, or Part D) cost-sharing rules.

Coordination With AWV, IPPE, and Other Medicare Preventive Services

AWV and IPPE Coordination

The IBT for Obesity benefit coordinates closely with the Annual Wellness Visit (Section 1861(hhh) SSA) and the Initial Preventive Physical Examination (Section 1861(ww) SSA). Both visits include BMI calculation as part of the standard health risk assessment. A BMI ≥30 finding triggers a clinical conversation about IBT eligibility and, where appropriate, initiation of the 12-month IBT course.

Coordination With Other Behavioral Counseling Services

Medicare covers several behavioral counseling preventive services that may be clinically relevant alongside IBT for Obesity:

• Cardiovascular Disease Behavioral Counseling (NCD 210.11): Annual behavioral counseling for cardiovascular disease prevention, also under Section 1861(ddd) authority.
• Diabetes Self-Management Training (DSMT): For beneficiaries with diabetes, covered under Section 1861(qq) SSA.
• Medical Nutrition Therapy (MNT): For beneficiaries with diabetes or chronic kidney disease, covered under Section 1861(s)(2)(V) SSA.
• Medicare Diabetes Prevention Program (MDPP): For beneficiaries at risk of type 2 diabetes, with BMI ≥25 (≥23 for Asian individuals) and elevated A1C or fasting glucose, covered under Section 1861(ddd) authority. MDPP is delivered by approved suppliers (often community-based organizations) and follows a 1-year structured curriculum.

Beneficiaries with obesity and concurrent diabetes, prediabetes, or cardiovascular disease may be eligible for multiple overlapping benefits. Coordination across these benefits is generally permitted, although individual benefit eligibility requires meeting each benefit's specific criteria.

Coordination With Bariatric Surgery (NCD 100.1)

For beneficiaries with BMI ≥35 kg/m² who have at least one obesity-related comorbidity, bariatric surgery coverage under NCD 100.1 provides an additional treatment option. The IBT benefit's "failed previous medical management" framework may be relevant to bariatric surgery eligibility documentation, although IBT is not a strict prerequisite to bariatric surgery under NCD 100.1.

Following the 2024 NCD 100.1 reconsideration removing the facility certification requirement, bariatric surgery is available at any Medicare-certified hospital, broadening access particularly in rural Georgia counties where MBSAQIP/ASMBS certified facilities had been limited.

The Georgia Bariatric and Obesity Medicine Landscape

For Georgia Medicare beneficiaries, the IBT benefit operates within a state landscape that includes:

Major Academic and Community Bariatric Programs

• Emory Bariatric Center — Academic bariatric and metabolic surgery program offering all four NCD 100.1-covered procedures. MBSAQIP accredited (relevant pre-2024 NCD reconsideration; post-2024 not a Medicare coverage requirement).
• Wellstar Bariatric Surgery — Major metro Atlanta bariatric program across multiple campuses.
• Piedmont Healthcare Bariatric — Multi-campus bariatric program across the Piedmont system.
• Northside Hospital Bariatric Services — Atlanta-area bariatric program.
• Augusta University Bariatric and Metabolic Surgery — Augusta-region academic bariatric program.
• Atrium Health Navicent Bariatric Surgery — Macon-region bariatric program.

Obesity Medicine Specialty Programs

In addition to the surgical programs above, several Georgia health systems have developed obesity medicine specialty clinics that integrate IBT, pharmacotherapy, and bariatric surgery referral pathways. Obesity medicine board certification is offered by the American Board of Obesity Medicine.

Federally Qualified Health Centers and Rural Access

Georgia's federally qualified health center network increasingly integrates IBT into primary care, particularly important for rural Georgia Medicare beneficiaries whose access to specialty obesity medicine and bariatric surgery is more limited. FQHCs in Georgia provide IBT as part of comprehensive primary care, with sliding-scale fees for uninsured or underinsured patients (Medicare patients receive standard IBT coverage under NCD 210.12).

Community Resources

• Obesity Action Coalition (1-800-717-3117) — National advocacy and support organization with patient resources.
• American Society for Metabolic and Bariatric Surgery (ASMBS) — Professional society maintaining patient resources.
• The Obesity Society — Professional society on obesity science and treatment.

Best Practices for Georgia Medicare Beneficiaries

1. Have your BMI calculated and documented at every annual visit. BMI is the entry criterion for IBT eligibility, and routine documentation ensures that you are aware of where you stand and can initiate the IBT pathway when appropriate.

2. Ask your primary care provider directly about IBT for Obesity if your BMI is ≥30 kg/m². Some primary care providers are not familiar with the NCD 210.12 framework; explicit conversation initiated by the beneficiary often accelerates engagement with the benefit.

3. Confirm the IBT sessions are billed under HCPCS G0447 (or G0473 for group) with $0 cost-sharing. If you receive a Medicare Summary Notice showing cost-sharing for an obesity counseling session, contact your provider's billing office to verify the correct preventive code was used.

4. Plan to commit to the full 12-month course. The IBT benefit is structured around a 12-month period, with the first six months designed for intensive behavior change and the second six months designed for maintenance. Skipping sessions reduces the effectiveness of the intervention.

5. Keep a food diary, activity log, and weight log between sessions. Self-monitoring is one of the most consistently effective behavioral change techniques in obesity treatment. Providers use the self-monitoring data to guide adjustments to your behavioral plan.

6. Aim for steady, modest weight loss in the first six months. The 3 kg (6.6 pound) six-month threshold is achievable for most beneficiaries with consistent behavioral change, representing approximately 1 pound of loss per month. Faster weight loss is not necessarily better and may not be sustainable.

7. If you have diabetes, coordinate IBT with diabetes management. Many diabetes medications (insulin, sulfonylureas) contribute to weight gain and may need adjustment as weight loss progresses. Conversely, GLP-1 receptor agonists for diabetes (Ozempic, Mounjaro) often produce additional weight loss that may interact favorably with the IBT six-month threshold.

8. If you have cardiovascular disease, ask about Wegovy coverage under the 2024 CMS reinterpretation. Beneficiaries with established cardiovascular disease and BMI ≥27 kg/m² may be eligible for Wegovy coverage under Part D following the SELECT trial-based 2024 reinterpretation.

9. Coordinate IBT with management of obesity-related conditions. Sleep apnea (treated with CPAP under DME coverage), osteoarthritis (treated with physical therapy and joint care), nonalcoholic fatty liver disease, and other obesity-related conditions can be managed in parallel with IBT.

10. Consider bariatric surgery if BMI ≥35 with obesity-related comorbidity and prior medical management has been insufficient. Bariatric surgery under NCD 100.1 is an established and effective treatment option for severe obesity, and the 2024 NCD 100.1 reconsideration broadened access by removing the facility certification requirement.

11. Use the AWV health risk assessment as a routine entry point to IBT. Most Georgia primary care practices include BMI calculation in the AWV health risk assessment, and the AWV is an efficient entry point to IBT initiation.

12. If your six-month weight loss is below the 3 kg threshold, do not view it as failure. The threshold determines continued eligibility for months 7-12 monthly sessions in the current cycle but does not preclude initiating a fresh IBT course in a future year if BMI remains ≥30.

13. Use behavioral health support if mood disorders, binge eating disorder, or other psychological factors are contributing to obesity. Medicare covers mental health services under Part B, and the CAA 2023 expansion of the Medicare mental health provider workforce to include marriage and family therapists and mental health counselors effective January 1, 2024 has broadened access.

14. Use GeorgiaCares SHIP (1-866-552-4464) or the Medicare Rights Center (1-800-333-4114) for Medicare coverage questions related to IBT, bariatric surgery, anti-obesity medications, or related obesity care.

Common Issues Georgia Medicare Beneficiaries Encounter

1. IBT is offered but billed under a non-preventive code, triggering cost-sharing. Verify the sessions were billed as G0447 (or G0473) and contact the provider's billing office if a different code was used.

2. Primary care providers unfamiliar with NCD 210.12 do not offer IBT despite BMI ≥30. Some primary care providers have not implemented IBT workflows. Beneficiaries can advocate for the benefit, request referral to a primary care provider who does offer IBT, or in some areas access IBT through an FQHC that has integrated the benefit.

3. IBT is offered by a specialty (non-primary-care) provider and is therefore not covered under NCD 210.12. Bariatric surgery practices, endocrinology clinics, and obesity medicine specialty clinics may offer obesity counseling, but the NCD 210.12 benefit is restricted to primary care settings. Specialty obesity counseling may be furnished but billed under different codes (e.g., evaluation and management codes) with standard cost-sharing.

4. Registered dietitian counseling is offered but not under G0447/G0473. RDs are not the qualifying providers under NCD 210.12. RD services may be available under Medical Nutrition Therapy (MNT) for beneficiaries with diabetes or chronic kidney disease, or under Medicare Diabetes Prevention Program (MDPP), but these are separate benefits with different eligibility criteria and cost-sharing rules.

5. The six-month weight loss threshold is not met and the beneficiary is told they "failed" IBT. The threshold is a Medicare coverage determination rule, not a clinical judgment about the beneficiary or about obesity treatment. Beneficiaries who do not meet the threshold can be re-evaluated for a future IBT course and may benefit from coordination with bariatric surgery or pharmacotherapy.

6. Anti-obesity medications are not covered under Part D for primary obesity treatment. The Part D weight loss drug exclusion remains in effect. Beneficiaries with established cardiovascular disease and BMI ≥27 may access Wegovy under the 2024 CMS reinterpretation. Beneficiaries with diabetes may access GLP-1 receptor agonists under the diabetes indication. Beneficiaries without these qualifying indications face out-of-pocket costs typically exceeding $1,000 per month.

7. Bariatric surgery is recommended but the local hospital was not previously MBSAQIP/ASMBS certified. Following the 2024 NCD 100.1 reconsideration, facility certification is no longer required for Medicare coverage. Surgery is available at any Medicare-certified hospital that performs the procedures.

8. Telehealth coverage of IBT is unclear. Medicare's telehealth coverage of behavioral counseling services has expanded substantially since 2020. Current telehealth coverage rules for G0447 should be confirmed with the provider's billing office.

9. The IBT benefit is offered but the beneficiary's BMI is below 30. Beneficiaries with BMI between 25 and 30 (overweight but not obese under WHO definitions) are not eligible for NCD 210.12 IBT but may be eligible for the Medicare Diabetes Prevention Program (MDPP) if they have prediabetes risk markers, or for cardiovascular disease behavioral counseling (NCD 210.11) if they have CVD risk factors.

10. Coordination across multiple Medicare behavioral counseling benefits creates documentation complexity. Beneficiaries enrolled in IBT, MDPP, MNT, DSMT, and behavioral health services should ensure each benefit is properly documented and billed under the appropriate codes.

11. Dual-eligible beneficiaries may have Medicaid wraparound coverage for related services. Georgia Medicaid covers some weight management and nutrition services beyond Medicare's coverage, and dual eligibles may access wraparound benefits.

12. Medicare Advantage plans may add supplemental obesity-related benefits. Some Medicare Advantage plans offer additional weight management, gym membership, nutrition counseling, or anti-obesity medication coverage as supplemental benefits beyond standard Part B IBT coverage. Beneficiaries should check their plan's evidence of coverage.

13. The 12-month IBT course concludes but obesity remains. Obesity is a chronic condition, and IBT is one component of ongoing management. Beneficiaries who complete an IBT course may pursue subsequent IBT courses, bariatric surgery evaluation, pharmacotherapy where eligible, or continued self-management with primary care follow-up.

14. Family members and caregivers can play important supportive roles. Behavioral change is more sustainable with social support. Family members can support the beneficiary by participating in food planning, joining activity routines, and providing encouragement during difficult periods.

Worked Examples for Georgia Medicare Beneficiaries

Example 1 — Fulton County 68-Year-Old BMI 33 IBT 12-Month Course With ≥6.6 lb Loss at Six Months

A 68-year-old woman in Fulton County presents to her Emory Primary Care internist for her Annual Wellness Visit. Her BMI is calculated at 33 kg/m² (weight 198 pounds, height 5 feet 5 inches). The internist documents the BMI ≥30 finding during the AWV and discusses the Medicare IBT for Obesity benefit. The beneficiary agrees to begin the 12-month course. The internist initiates IBT with weekly sessions in month 1, billing G0447 (15 minutes face-to-face) at $0 cost-sharing under the ACA Section 4104 waiver. Sessions focus on dietary assessment (high carbohydrate intake at evening meals, frequent restaurant meals), physical activity assessment (limited by knee osteoarthritis), and goal-setting (target 1 pound per week loss, daily 10-minute walks expanding over time). Across months 2-6, every-other-week G0447 sessions reinforce behavioral changes and address barriers. At the six-month visit, the beneficiary has lost 11 pounds, exceeding the 6.6 pound threshold. The internist documents the threshold determination and continues monthly G0447 sessions for months 7-12. At the 12-month conclusion, the beneficiary has lost 18 pounds total, with BMI now at 30.0 kg/m² and improved blood pressure, lipid profile, and knee pain. The internist arranges continued primary care follow-up for sustained self-management.

Example 2 — Worth County 70-Year-Old BMI 35 IBT Plus FQHC Nutrition Support

A 70-year-old man in Worth County (rural southwest Georgia) presents to his FQHC primary care provider for an established patient visit. His BMI is 35 kg/m² (weight 245 pounds, height 5 feet 10 inches). The FQHC offers IBT integrated with FQHC-funded nutrition support staff who provide complementary (not Medicare-billed) education. The IBT itself is billed under G0447 at $0 cost-sharing. The beneficiary attends weekly sessions in month 1 and every-other-week sessions in months 2-6. At the six-month visit, the beneficiary has lost 9 pounds, meeting the threshold. Months 7-12 monthly sessions continue. At 12 months, the beneficiary has lost 15 pounds. The FQHC nutrition support continues without Medicare billing. The beneficiary's A1C decreases from 6.4% (prediabetes) to 5.9% across the year.

Example 3 — Cobb County 67-Year-Old BMI 31 IBT Not Meeting Six-Month Threshold Transition

A 67-year-old woman in Cobb County presents to her Wellstar primary care provider for AWV. BMI is 31 kg/m². IBT is initiated with weekly G0447 sessions in month 1 and every-other-week sessions in months 2-6. At the six-month visit, the beneficiary has lost 4 pounds, below the 6.6 pound threshold. The provider documents the threshold determination, explains that the months 7-12 monthly sessions are not covered in this 12-month cycle, and discusses alternatives: continued self-monitoring with periodic primary care follow-up, consideration of bariatric surgery referral if appropriate (BMI 31 is below the NCD 100.1 threshold of 35 with comorbidity), consideration of mental health support if mood or stress-related eating is contributing, and re-evaluation for a fresh IBT course in 12 months if BMI remains ≥30. The beneficiary continues general primary care follow-up and is re-engaged for a fresh IBT course in the subsequent year.

Example 4 — DeKalb County 72-Year-Old BMI 42 IBT Plus Bariatric Surgery Evaluation

A 72-year-old man in DeKalb County, with BMI 42 kg/m² (weight 280 pounds, height 5 feet 9 inches), type 2 diabetes, hypertension, and obstructive sleep apnea, presents to his Piedmont primary care provider. The provider documents the BMI and discusses the IBT benefit alongside bariatric surgery evaluation given the BMI ≥35 with multiple comorbidities. The beneficiary initiates IBT under G0447 and is referred to the Piedmont Bariatric Surgery program for evaluation. Over the first six months of IBT, the beneficiary loses 12 pounds (exceeding threshold) and completes the bariatric surgery pre-operative workup. The beneficiary undergoes sleeve gastrectomy at month 7 (covered under NCD 100.1, no MBSAQIP facility requirement post-2024 reconsideration). Months 7-12 IBT continues post-surgery, focusing on dietary adaptation and physical activity. At 12 months post-IBT initiation (5 months post-surgery), the beneficiary has lost 65 pounds total, A1C has decreased from 7.8% to 6.0% with reduction in diabetes medications, blood pressure has improved, and CPAP requirement has decreased.

Example 5 — Bibb County 65-Year-Old BMI 38 IBT Plus GLP-1 (Wegovy) for Cardiovascular Indication

A 65-year-old man in Bibb County, with BMI 38 kg/m², established coronary artery disease (prior myocardial infarction 3 years earlier with drug-eluting stent placement), and hypertension, presents to his Atrium Health Navicent primary care provider. Following the 2024 CMS reinterpretation extending Part D coverage of Wegovy for cardiovascular indications under the SELECT trial, the provider initiates Wegovy (semaglutide 2.4 mg weekly subcutaneous injection) under Part D coverage. Simultaneously, the provider initiates IBT under G0447 to support the lifestyle changes that will maximize the medication's effectiveness. Over the first six months, the beneficiary loses 28 pounds (well above threshold), supported by Wegovy's effect on appetite and IBT's behavioral structure. Months 7-12 IBT continues with focus on sustained behavior change. At 12 months, the beneficiary has lost 40 pounds total, with BMI now at 32 kg/m², improved cardiovascular markers, and continued Wegovy therapy.

Example 6 — Hall County 75-Year-Old BMI 36 Group IBT (G0473) Under Medicare Advantage

A 75-year-old woman in Hall County, enrolled in a Medicare Advantage plan, with BMI 36 kg/m², presents to her Northeast Georgia Medical Center primary care provider. The practice offers group IBT (HCPCS G0473) as a complementary delivery model alongside individual G0447 sessions. The beneficiary enrolls in the group IBT program, attending 30-minute group sessions weekly in month 1, every-other-week in months 2-6, and monthly in months 7-12 (conditional on six-month threshold). The group format provides peer support and shared learning. At the six-month visit, the beneficiary has lost 8 pounds, meeting the threshold. The Medicare Advantage plan covers G0473 at $0 cost-sharing matching Original Medicare. At 12 months, the beneficiary has lost 14 pounds and reports significant value from the group format peer support.

Frequently Asked Questions

1. What is Medicare's Intensive Behavioral Therapy for Obesity benefit? Medicare's IBT for Obesity benefit is a multi-session behavioral therapy intervention for beneficiaries with BMI ≥30 kg/m², delivered in a primary care setting by a qualified primary care provider, structured around a weekly-biweekly-monthly schedule across a 12-month period, billed under HCPCS G0447 (individual) or G0473 (group), with $0 cost-sharing under the ACA Section 4104 waiver.

2. What federal authority covers the benefit? Section 1861(ddd) of the Social Security Act, with the specific coverage determination in NCD 210.12 effective November 29, 2011.

3. Who is eligible? Medicare beneficiaries with BMI ≥30 kg/m². The benefit is universal among Medicare beneficiaries meeting the BMI threshold.

4. Where must IBT be performed? In a primary care setting: family medicine, internal medicine, geriatric medicine, FQHC, or RHC. Specialty practices, emergency department, inpatient, SNF, and hospice do not qualify.

5. Who can deliver IBT? Qualified primary care providers: physicians (MDs/DOs) in primary care specialties, NPs, PAs, and CNSs practicing in primary care. RDs, CDEs, and nutrition professionals are not qualifying providers under NCD 210.12.

6. What is the session schedule? Weekly for month 1 (4 sessions), every other week for months 2-6 (10 additional sessions), and monthly for months 7-12 (6 additional sessions, conditional on the six-month weight loss threshold). Maximum of approximately 22 sessions across the 12-month period.

7. What is the six-month weight loss threshold? At least 3 kg (approximately 6.6 pounds) of weight loss from baseline at the six-month visit. Beneficiaries who meet the threshold are eligible for months 7-12 monthly sessions; those who do not are not eligible for the months 7-12 sessions in that 12-month cycle.

8. What happens if I do not meet the six-month threshold? You are not eligible for the months 7-12 monthly sessions in that 12-month cycle. You may be re-evaluated for a fresh IBT course in a future year if BMI remains ≥30. The threshold is a Medicare coverage rule, not a clinical judgment about you.

9. What is the cost-sharing? Zero. Under ACA Section 4104, the Part B deductible and the 20% coinsurance do not apply.

10. What HCPCS codes are used? G0447 for 15-minute face-to-face individual IBT sessions, G0473 for 30-minute group IBT sessions (2-10 patients).

11. How does IBT coordinate with bariatric surgery? Bariatric surgery under NCD 100.1 covers beneficiaries with BMI ≥35 and at least one obesity-related comorbidity. IBT is not a strict prerequisite to bariatric surgery, but the "failed previous medical management" framework may make IBT participation relevant to surgical evaluation documentation. The 2024 NCD 100.1 reconsideration removed the facility certification requirement, broadening surgical access.

12. Does Medicare cover anti-obesity medications? Medicare Part D excludes drugs prescribed for weight loss under the statutory exclusion dating to the 2003 MMA. Exceptions: (1) GLP-1 receptor agonists prescribed for diabetes (Ozempic, Mounjaro) are covered for the diabetes indication; (2) Wegovy (semaglutide 2.4 mg) is covered under Part D for cardiovascular risk reduction in beneficiaries with established cardiovascular disease and BMI ≥27, following the 2024 CMS reinterpretation under SELECT trial results; (3) anti-obesity medications for primary obesity treatment without these qualifying indications remain excluded.

13. What is the 2024 CMS reinterpretation of GLP-1 coverage? In March 2024, following the SELECT trial publication (November 2023) and FDA approval of an additional cardiovascular risk reduction indication for Wegovy, CMS issued guidance clarifying that Part D plans may cover Wegovy for cardiovascular risk reduction in beneficiaries with established cardiovascular disease and BMI ≥27. The reinterpretation did not extend coverage to GLP-1s for primary obesity treatment without an established cardiovascular indication.

14. What is the 2024 NCD 100.1 reconsideration? CMS reconsidered NCD 100.1 (bariatric surgery coverage) in 2024 and removed the requirement that bariatric surgery be performed at an MBSAQIP/ASMBS certified facility. Bariatric surgery is now covered at any Medicare-certified hospital meeting standard quality requirements.

15. How does IBT coordinate with the AWV and IPPE? Both the AWV (Section 1861(hhh)) and the IPPE (Section 1861(ww)) include BMI calculation as part of the standard health risk assessment. A BMI ≥30 finding may trigger initiation of the IBT pathway.

16. How does IBT coordinate with the Medicare Diabetes Prevention Program (MDPP)? MDPP is a separate Medicare benefit for beneficiaries at risk of type 2 diabetes (BMI ≥25, ≥23 for Asian beneficiaries, with elevated A1C or fasting glucose). MDPP and IBT serve different but overlapping populations; some beneficiaries may be eligible for both at different times.

17. How does IBT coordinate with Medical Nutrition Therapy (MNT)? MNT is a separate Medicare benefit under Section 1861(s)(2)(V) for beneficiaries with diabetes or chronic kidney disease, delivered by a registered dietitian. MNT may be furnished alongside IBT for eligible beneficiaries.

18. Can I do IBT via telehealth? Medicare's telehealth coverage of behavioral counseling services expanded substantially since 2020. Current telehealth coverage rules for G0447 should be confirmed with your provider's billing office.

19. What if my BMI is between 25 and 30? You are not eligible for NCD 210.12 IBT but may be eligible for MDPP (with prediabetes risk markers) or for cardiovascular disease behavioral counseling under NCD 210.11.

20. What if my Medicare Advantage plan has additional weight management benefits? Some MA plans offer supplemental benefits (gym memberships, additional nutrition counseling, etc.) beyond standard Part B IBT coverage. Check your plan's evidence of coverage for supplemental benefits.

21. How many IBT courses can I have in a lifetime? NCD 210.12 does not specify a lifetime limit. Beneficiaries who complete a 12-month IBT course and continue to have BMI ≥30 may be evaluated for a fresh course in a future year if clinically appropriate.

22. Are there age limits? No specific age limits beyond Medicare eligibility (typically 65+, or earlier with SSDI/ESRD).

23. What is the role of exercise in IBT? Physical activity is one of the core behavioral components addressed in IBT, alongside diet, self-monitoring, problem-solving, and other techniques. Typical recommendations include working toward 150 minutes per week of moderate activity, adapted to the individual's abilities and constraints.

24. What is the role of psychological factors in IBT? IBT addresses behavioral factors directly; psychological factors such as mood disorders, binge eating disorder, and stress-related eating may require additional mental health support that can be provided alongside IBT under Medicare Part B mental health benefits.

25. Where can I find Georgia-specific resources? GeorgiaCares SHIP (1-866-552-4464), Georgia Department of Public Health (404-657-2700), major Georgia bariatric programs (Emory, Wellstar, Piedmont, Northside, Augusta University, Atrium Health Navicent), and the Obesity Action Coalition (1-800-717-3117) are key resources.

26. How do I find a primary care provider in Georgia who offers IBT? Contact your current primary care provider's office to ask about IBT availability. If your provider does not offer IBT, GeorgiaCares SHIP, Medicare's provider lookup tools, and your Medicare Advantage plan's network directory can help identify providers in your area.

Contacts and Resources

This guide reflects Medicare IBT for Obesity coverage as of 2026-05-14 and applies to Georgia Medicare beneficiaries.